10.1242/jeb.204.18.3201 52
Regulatory Considerations FDA Approval -Tesamorelin is FDA-approved for reducing visceral fat in patients with HIV-associated lipodystrophy, while Sermorelin is not FDA-approved for any specific indication, though it is commonly prescribed by some physicians for off-label uses, such as muscle growth, anti-aging, and general growth hormone optimization
Visible weight loss usually follows after one to two months of consistent use
Keeping them in their original packaging
This isn't a legal grey area: purchasing and importing an unapproved therapeutic good such as retatrutide is illegal
NAD+ | SERMORELIN SEMAGLUTIDE | NAD+ | SERMORELIN $395/month with Micro dose of Semaglutide SEMAGLUTIDE | NAD+ | SERMORELIN $495/month with standard dose of Semaglutide TIRZEPATIDE | NAD+ | SERMORELIN $495/month with Micro dose of Tirzepatide TIRZEPATIDE | NAD+ | SERMORELIN $595/month with standard dose of Tirzepatide Our medical-grade, prescription-only GHK-Cu Hair & Scalp Therapy is designed to restore follicle health, improve circulation, and support natural, thicker hair growth over time